NASDAQ$ZIMV
ZimVie Inc · Q2 2022 earnings
Q2 2022 earnings · · Investor relations
Briefing
ZimVie's third-party net sales reached $233.4 million, with a net loss of ($8.7) million and a diluted EPS of ($0.33).
ZimVie reported a decrease in third-party net sales by (11.5%) on a reported basis and (8.3%) on a constant currency basis compared to Q2 2021. The company's net loss increased to ($8.7) million, and diluted EPS was ($0.33). However, cash and cash equivalents increased to $130.1 million.
- Third-party net sales were $233.4 million, a decrease of (11.5%) year-over-year.
- Net loss was ($8.7) million, with a net loss margin of (3.7%).
- Diluted EPS was ($0.33), and adjusted diluted EPS was $0.67.
- Cash and cash equivalents totaled $130.1 million, up from $104.3 million at the end of Q1 2022.
Headline financials
Revenue & EPS history
ZimVie · Revenue · Quarterly
$235M
Forward guidance
ZimVie revised its full-year 2022 net sales guidance to $915 to $930 million and adjusted EPS guidance from $2.10-$2.30 to $1.80-$2.00, while reaffirming adjusted EBITDA margin guidance of flat to 50bps improvement from the prior year.
Tailwinds
- Reaffirming adjusted EBITDA margin guidance of flat to 50bps improvement from prior year margin of 13.1%.
- Expect dental business to deliver near the lower end of prior mid to high single digit growth in constant currency
Headwinds
- Revised net sales guidance to $915 to $930 million versus prior guidance of $1.0 billion due to greater than anticipated foreign exchange headwinds.
- Expect spine business to decline in the low double digits in constant currency.
- Revised adjusted EPS guidance from a range of $2.10 to $2.30 to $1.80 to $2.00 due primarily to lower sales.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 6 quarterly earnings reports
-1.7%
Avg return
Earnings day
-3.4%
Avg return
5 days after
-5.3%
Avg return
30 days after
44%
8 / 18 earnings
Positive
+24.0%
Q1 2023
Best reaction
-49.0%
Q4 2022
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q3 2025 | — | — | — | |
| Q2 2025 | -0.4% | -0.1% | +0.1% | |
| Q1 2025 | -4.4% | -4.8% | +2.2% | |
| Q4 2024 | -1.7% | +3.1% | -11.9% | |
| Q3 2024 | +0.6% | +5.5% | +6.2% | |
| Q2 2024 | -18.2% | -19.0% | -17.9% | |
| Q1 2024 | +5.7% | +4.8% | +0.8% | |
| Q4 2023 | -14.4% | -13.4% | -16.9% | |
| Q3 2023 | +5.4% | — | — | |
| Q2 2023 | -6.0% | — | — | |
| Q1 2023 | +24.0% | — | — | |
| Q4 2022 | -49.0% | — | — | |
| Q3 2021 | +20.0% | — | — | |
| Q3 2022 | +20.0% | — | — | |
| Q2 2021 | -8.2% | — | — | |
| Q2 2022 | -8.2% | — | — | |
| Q1 2021 | -6.5% | — | — | |
| Q4 2021 | +5.1% | — | — | |
| Q4 2020 | +5.1% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro